Quantcast
Channel: News-Medical.Net onsolis News Feed
Viewing all articles
Browse latest Browse all 26

BioDelivery Sciences International submits BUNAVAIL NDA to FDA

$
0
0
BioDelivery Sciences International, Inc. announced today that it engaged in a positive pre-New Drug Application meeting with the U.S. Food and Drug Administration regarding BUNAVAIL for the maintenance treatment of opioid dependence.

Viewing all articles
Browse latest Browse all 26

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>